Silhouette
Upgrade to view details

Peter M Pushko

Medigen, Inc.

Message

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II
Medigen, Inc.
Principal Investigator
HHS 2 $813K 02/01/17 01/31/18
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II
Medigen, Inc.
Principal Investigator
HHS 2 $812K 02/01/16 01/31/17
Polyvalent Vaccines to Protect Poultry from Avian Influenza
Medigen, Inc.
Principal Investigator
USDA 2 $396K 01/01/13 12/31/13
Novel DNA-Launched Attenuated Vaccine for VEE Virus
Medigen, Inc.
Principal Investigator
HHS 1 $300K 06/01/12 05/31/13
Trivalent Arenaviral Vaccine Based on Virus-Like Particle Vectors (VLPVs)
Medigen, Inc.
Principal Investigator
HHS 1 $222K 07/15/11 06/30/13
Novel DNA-Launched Attenuated Vaccine for VEE Virus
Medigen, Inc.
Principal Investigator
HHS 1 $300K 06/01/11 05/31/12
Infectious DNA (i-DNA) Vaccine for Yellow Fever
Medigen, Inc.
Principal Investigator
HHS 1 $118K 01/15/11 10/31/12
Polyvalent Vaccine to Protect Poultry from Avian Influenza
Medigen, Inc.
Principal Investigator
USDA 1 $99.9K 01/01/11 12/31/11